These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9724373)

  • 1. Feasibility of imaging photodynamic injury to tumours by high-resolution positron emission tomography.
    Moore JV; Waller ML; Zhao S; Dodd NJ; Acton PD; Jeavons AP; Hastings DL
    Eur J Nucl Med; 1998 Sep; 25(9):1248-54. PubMed ID: 9724373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.
    Tatsumi M; Nakamoto Y; Traughber B; Marshall LT; Geschwind JF; Wahl RL
    Cancer Res; 2003 Oct; 63(19):6252-7. PubMed ID: 14559811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution PET imaging for in vivo monitoring of tumor response after photodynamic therapy in mice.
    Lapointe D; Brasseur N; Cadorette J; La Madeleine C; Rodrigue S; van Lier JE; Lecomte R
    J Nucl Med; 1999 May; 40(5):876-82. PubMed ID: 10319764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography--a study evaluating [18F]Fluoro-2-deoxy-D-glucose.
    Bentzen L; Keiding S; Horsman MR; Falborg L; Hansen SB; Overgaard J
    Acta Oncol; 2000; 39(5):629-37. PubMed ID: 11093372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering PDT-induced inflammatory responses using real-time FDG-PET in a mouse tumour model.
    Cauchon N; Hasséssian HM; Turcotte E; Lecomte R; van Lier JE
    Photochem Photobiol Sci; 2014 Oct; 13(10):1434-43. PubMed ID: 25058054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo magnetic resonance imaging of the effects of photodynamic therapy.
    Dodd NJ; Moore JV; Poppitt DG; Wood B
    Br J Cancer; 1989 Aug; 60(2):164-7. PubMed ID: 2765361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography of murine liver metastases and the effects of treatment by combretastatin A-4.
    Zhao S; Moore JV; Waller ML; McGown AT; Hadfield JA; Pettit GR; Hastings DL
    Eur J Nucl Med; 1999 Mar; 26(3):231-8. PubMed ID: 10079313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting efficacy of photodynamic therapy by real-time FDG-PET in a mouse tumour model.
    Cauchon N; Turcotte E; Lecomte R; Hasséssian HM; Lier JE
    Photochem Photobiol Sci; 2012 Feb; 11(2):364-70. PubMed ID: 22234417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FPPRGD2 and 18F-FDG PET of response to Abraxane therapy.
    Sun X; Yan Y; Liu S; Cao Q; Yang M; Neamati N; Shen B; Niu G; Chen X
    J Nucl Med; 2011 Jan; 52(1):140-6. PubMed ID: 21149494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is 18F-FDG-PET suitable for therapy monitoring after palliative photodynamic therapy of non-resectable hilar cholangiocarcinoma?].
    Müller D; Wiedmann M; Kluge R; Berr F; Mössner J; Sabri O; Caca K
    Z Gastroenterol; 2005 May; 43(5):439-43. PubMed ID: 15871065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiolabelled 5'-iodo-2'-deoxyuridine: a promising alternative to [18F]-2-fluoro-2-deoxy-D-glucose for PET studies of early response to anticancer treatment.
    Carnochan P; Brooks R
    Nucl Med Biol; 1999 Aug; 26(6):667-72. PubMed ID: 10587105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.
    Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO
    Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superimposition of PET images using 18F-fluorodeoxyglucose with magnetic resonance images in patients with pancreatic carcinoma.
    Benyounes H; Smith FW; Campbell C; Evans NT; Norton MY; Mikecz P; Heys SD; Bruce D; Eremin O; Sharp PF
    Nucl Med Commun; 1995 Jul; 16(7):575-80. PubMed ID: 7478396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schwannoma of the extremities: the role of PET in preoperative planning.
    Ahmed AR; Watanabe H; Aoki J; Shinozaki T; Takagishi K
    Eur J Nucl Med; 2001 Oct; 28(10):1541-51. PubMed ID: 11685498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma.
    Hoffmann M; Vogelsang H; Kletter K; Zettinig G; Chott A; Raderer M
    Gut; 2003 Mar; 52(3):347-51. PubMed ID: 12584214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A small animal positron emission tomography study of the effect of chemotherapy and hormonal therapy on the uptake of 2-deoxy-2-[F-18]fluoro-D-glucose in murine models of breast cancer.
    Aliaga A; Rousseau JA; Cadorette J; Croteau E; van Lier JE; Lecomte R; Bénard F
    Mol Imaging Biol; 2007; 9(3):144-50. PubMed ID: 17334852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography agent 2-deoxy-2-[18F]fluoro-D-glucose has a therapeutic potential in breast cancer.
    Moadel RM; Nguyen AV; Lin EY; Lu P; Mani J; Blaufox MD; Pollard JW; Dadachova E
    Breast Cancer Res; 2003; 5(6):R199-205. PubMed ID: 14580255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET imaging of musculoskeletal tumours with fluorine-18 alpha-methyltyrosine: comparison with fluorine-18 fluorodeoxyglucose PET.
    Watanabe H; Inoue T; Shinozaki T; Yanagawa T; Ahmed AR; Tomiyoshi K; Oriuchi N; Tokunaga M; Aoki J; Endo K; Takagishi K
    Eur J Nucl Med; 2000 Oct; 27(10):1509-17. PubMed ID: 11083540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer.
    Adams S; Baum RP; Stuckensen T; Bitter K; Hör G
    Eur J Nucl Med; 1998 Sep; 25(9):1255-60. PubMed ID: 9724374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.